Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains

被引:118
作者
Hopkins, WJ
Gendron-Fitzpatrick, A
Balish, E
Uehling, DT
机构
[1] Univ Wisconsin, Dept Surg, Madison, WI 53792 USA
[2] Univ Wisconsin, Res Anim Resource Ctr, Madison, WI 53792 USA
关键词
D O I
10.1128/IAI.66.6.2798-2802.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recurrent urinary tract infections (UTIs) are a significant clinical problem for many women; however, host susceptibility factors have not been completely defined. The mouse model of induced UTI provides an experimental environment in which to identify specific host characteristics that are important in initial bacterial colonization of the urinary tract and in resolution of an infection. This study examined initial susceptibility, bacterial clearance, and host defense mechanisms during induction and resolution of Escherichia coli UTIs in genetically distinct strains of mice. Of the ten inbred strains tested, six (BALB/c, C3H/HeN, C57BL/6, DBA.1, DBA.2, and AKR) showed progressive resolution of bladder infections over a 14-day period. A constant, low-level bladder infection was observed in SWR and SJL mice. High bladder infection levels persisted over the 14-day study period in C3H/HeJ and Q3H/OuJ mice, Kidney infection levels generally correlated with bladder infection levels, especially in C3H/HeJ and C3H/OuJ mice, the two most susceptible strains, in which infections became more severe with time after challenge. The degree of inflammation in bladder and kidneys, as well as antibody-forming cell responses, positively correlated with infection intensity in all strains except C3H/HeJ, which had minimal inflammation despite high infection levels. These results demonstrate two important aspects of host defense against UTI, First, the innate immune response to an infection in the bladder or kidneys consists primarily of local inflammation, which is followed by an adaptive response characterized in part by an antibody response to the infecting bacteria. Second, a UTI will be spontaneously resolved in most cases; however, in mice with specific genetic backgrounds, a UTI can persist for an extended length of time. The latter result strongly suggests that the presence or absence of specific host genes will determine how effectively an E, coli UTI will be resolved.
引用
收藏
页码:2798 / 2802
页数:5
相关论文
共 29 条
[11]   Lipopolysaccharide-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection [J].
Hopkins, WJ ;
GendronFitzpatrick, A ;
McCarthy, DO ;
Haine, JE ;
Uehling, DT .
INFECTION AND IMMUNITY, 1996, 64 (04) :1369-1372
[12]   RESOLUTION TIME OF ESCHERICHIA-COLI CYSTITIS IS CORRELATED WITH LEVELS OF PREINFECTION ANTIBODY TO THE INFECTING ESCHERICHIA-COLI STRAIN [J].
HOPKINS, WJ ;
UEHLING, DT .
UROLOGY, 1995, 45 (01) :42-46
[13]   WESTERN-BLOT-ANALYSIS OF ANTI-ESCHERICHI COLI SERUM IMMUNOGLOBULINS IN WOMEN SUSCEPTIBLE TO RECURRENT URINARY-TRACT INFECTIONS [J].
HOPKINS, WJ ;
XING, YN ;
DAHMER, LA ;
BALISH, E ;
UEHLING, DT .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) :1612-1616
[14]   INDUCTION OF URINARY-TRACT INFECTION BY INTRAURETHRAL INOCULATION WITH ESCHERICHIA-COLI REFINING THE MURINE MODEL [J].
HOPKINS, WJ ;
HALL, JA ;
CONWAY, BP ;
UEHLING, DT .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :462-465
[15]   LOCAL AND SYSTEMIC ANTIBODY-RESPONSES ACCOMPANY SPONTANEOUS RESOLUTION OF EXPERIMENTAL CYSTITIS IN CYNOMOLGUS MONKEYS [J].
HOPKINS, WJ ;
UEHLING, DT ;
BALISH, E .
INFECTION AND IMMUNITY, 1987, 55 (09) :1951-1956
[16]   ABO BLOOD-GROUP, SECRETOR STATE, AND SUSCEPTIBILITY TO RECURRENT URINARY-TRACT INFECTION IN WOMEN [J].
KINANE, DF ;
BLACKWELL, CC ;
BRETTLE, RP ;
WEIR, DM ;
WINSTANLEY, FP ;
ELTON, RA .
BRITISH MEDICAL JOURNAL, 1982, 285 (6334) :7-9
[17]  
KOLSCH E, 1971, European Journal of Immunology, V1, P201, DOI 10.1002/eji.1830010310
[18]  
Kunin C.M., 1997, Urinary tract infections. Detection, prevention
[19]   URINARY-TRACT INFECTIONS [J].
NEU, HC .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 :S63-S70
[20]  
PARSONS CL, 1986, UROL CLIN N AM, V13, P563